Research and innovation news

Manchester University NHS Foundation Trust’s (MFT) ground-breaking qUEST research, part of the Manchester Lung Health Checks programme, has been named among the top-recruiting cancer studies in Englan

Manchester doctors have played a leading role in global coronavirus research, which has found the first drug shown to increase survival rates in people hospitalised with COVID-19.

Manchester’s world-class health innovation campus – a joint venture between Manchester University NHS Foundation Trust and Manchester Science Partnerships (MSP) – takes a step forward.

A research study evaluating the presence of COVID-19 antibodies in children and young people is taking place at ourTrust.

A Wythenshawe Hospital patient with COVID-19 is the first Manchester University NHS Foundation Trust recruit to a clinical trial investigating the drug Anakinra to treat COVID-19.

Many MFT staff members are involving their children in our vitally important COVID-19 research, with some of them sharing their experiences.

MFT researcher urges frontline health professionals, including nurses and midwives, to be vigilant and make sure they have processes in place to report and record FGM,

More than 600 school children and teachers in Greater Manchester have taken part in a new voluntary coronavirus study, which is assessing the prevalence of COVID-19 in school pupils and teachers.